Article: Antimicrobial activity of HR810 against 419 strict anaerobic bacteria

HR810 and four other new beta-lactams were tested against 419 recent clinical anaerobic bacterial isolates. HR810 was found to have an antimicrobial spectrum most similar to that of cefotaxime, inhibiting 52.6% of Bacteroides fragilis group strains and 97.2% of all other anaerobic strains at an MIC of less than or equal to 16 micrograms/ml. Cefoxitin was found to have a narrower antimicrobial spectrum against the gram-positive anaerobic bacteria (8.4 to 10.1% less) than HR810 and cefotaxime, respectively.

Citing Articles

In vitro and in vivo antibacterial activities of E1077, a novel parenteral cephalosporin.

Toyosawa T, Miyazaki S, Tsuji A, Yamaguchi K, Goto S Antimicrob Agents Chemother. 1993; 37(1):60-6.

PMID: 8431019 PMC: 187605. DOI: 10.1128/AAC.37.1.60.

The synergistic effect of cefotaxime and desacetylcefotaxime against clinical isolates of anaerobic bacteria.

Devlin H, Boskovski L Drugs. 1988; 35 Suppl 2:45-50.

PMID: 3396488 DOI: 10.2165/00003495-198800352-00011.

In vitro antibacterial effects of cephalosporins.

Williams J, Moosdeen F Drugs. 1987; 34 Suppl 2:44-63.

PMID: 3319505 DOI: 10.2165/00003495-198700342-00006.

Antibacterial activities in vitro and in vivo and pharmacokinetics of cefquinome (HR 111V), a new broad-spectrum cephalosporin.

Limbert M, Isert D, Klesel N, Markus A, Seeger K, Seibert G Antimicrob Agents Chemother. 1991; 35(1):14-9.

PMID: 2014969 PMC: 244934. DOI: 10.1128/AAC.35.1.14.

References

1.

Reynolds A . The activity of nitro-compounds against Bacteroides fragilis is related to their electron affinity. J Antimicrob Chemother. 1981; 8(2):91-9. DOI: 10.1093/jac/8.2.91. View

2.

Tally F, Cuchural G, Jacobus N, Gorbach S, Aldridge K, Cleary T . Susceptibility of the Bacteroides fragilis group in the United States in 1981. Antimicrob Agents Chemother. 1983; 23(4):536-40. PMC: 184695. DOI: 10.1128/AAC.23.4.536. View

3.

Machka K, Braveny I . In vitro activity of HR 810, a new broad-spectrum cephalosporin. Eur J Clin Microbiol. 1983; 2(4):345-9. DOI: 10.1007/BF02019465. View

4.

Wiedemann B . HR 810, a cephalosporin with low affinity for Enterobacter cloacae beta-lactamase. Eur J Clin Microbiol. 1983; 2(4):352-4. DOI: 10.1007/BF02019467. View

5.

Bauernfeind A . Susceptibility of gram-positive aerobic cocci to the new cephalosporin HR 810. Eur J Clin Microbiol. 1983; 2(4):354-5. DOI: 10.1007/BF02019468. View

6.

Jones R, Thornsberry C, Barry A, Ayers L, Brown S, Daniel J . Disk diffusion testing, quality control guidelines, and antimicrobial spectrum of HR810, a fourth-generation cephalosporin, in clinical microbiology laboratories. J Clin Microbiol. 1984; 20(3):409-12. PMC: 271340. DOI: 10.1128/jcm.20.3.409-412.1984. View

7.

Seibert G, Limbert M, Winkler I, Dick T . The Antibacterial activity in vitro and beta-lactamase stability of the new cephalosporin HR 810 in comparison with five other cephalosporins and two aminoglycosides. Infection. 1983; 11(5):275-9. DOI: 10.1007/BF01641262. View

8.

Cuchural Jr G, Tally F, Jacobus N, Marsh P, Mayhew J . Cefoxitin inactivation by Bacteroides fragilis. Antimicrob Agents Chemother. 1983; 24(6):936-40. PMC: 185411. DOI: 10.1128/AAC.24.6.936. View

9.

Jones R, Thornsberry C, Barry A . In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin. Antimicrob Agents Chemother. 1984; 25(6):710-8. PMC: 185628. DOI: 10.1128/AAC.25.6.710. View

10.

Jones R, Barry A, Packer R . The activity of cefotaxime and desacetylcefotaxime alone and in combination against anaerobes and staphylococci. Diagn Microbiol Infect Dis. 1984; 2(3 Suppl):37S-46S. View

11.

Seibert G, Klesel N, Limbert M, Schrinner E, Seeger K, Winkler I . HR 810, a new parenteral cephalosporin with a broad antibacterial spectrum. Arzneimittelforschung. 1983; 33(8):1084-6. DOI: 10.1002/chin.198350201. View

Antimicrobial Activity of HR810 Against 419 Strict Anaerobic Bacteria